How we now treat COVID-19 pneumonia compared to 12 months ago makes a significant difference to survival.
I was motivated to improve the outcome for women with ovarian cancer by my experience as a junior doctor in London in 1985. But 36 years on, the results aren't what we'd hoped.
Australian researchers have identified the immune response associated with protection from COVID-19 – a discovery that may help cut the time it takes to develop new vaccines.
Will new guidelines on how to protect front-line workers acknowledge the coronavirus can spread via the air we breathe? It's time they did.
Researchers to examine new treatments for “ice” use, Crohn’s disease, spinal cord injuries, and new methods for detecting epidemics.
Research led by UNSW Sydney's Vice-Chancellor has found screening methods for ovarian cancer do not improve survival rates from the disease.
Misleading claims about COVID-19 vaccines can negatively impact public confidence in immunisation uptake, a new UNSW Sydney study reveals.
Tackling the scar tissue that shields pancreatic tumours from effective drug access is a promising advance in a notoriously hard-to-treat cancer.
Hepatitis C testing and treatment in prisons is key to reducing infections, a new study by the Kirby Institute has shown.
What is the difference between the mRNA vaccine and the adenovirus vaccine? Can the mRNA vaccine be tweaked when new variants develop?